An open-label, randomised controlled trial to investigate the safety of withdrawal of pharmacological treatment for recovered HER2 targeted therapy related cardiac dysfunction.
30 August 2026 (11:15 - 11:30)
Organised by: 
Slides
About the speaker
University College London, London (United Kingdom of Great Britain & Northern Ireland)
3 More presentations in this session
Doctor D. Leong (Hamilton, CA)
Doctor S. Lee (Seoul, KR)
Access the full session
The Event
ESC Congress 2026
30 August 2026
11:15 CET
You may be interested in
Congress Presentation
Congress Presentation
